Trump Pulls Heidi Overton's FDA Nomination on the Day the Senate Was Due to Vote
Source: Tobacco Reporter (Nov 2026)

Image: U.S. Food and Drug Administration / Wikimedia Commons (public domain)
President Donald Trump withdrew Heidi Overton's nomination to lead the Food and Drug Administration, citing insufficient support in Congress, according to a White House official. Tobacco Reporter reported the withdrawal on November 18, 2026.
The Senate HELP Committee had been scheduled to vote on her nomination that same day, November 18.
She faced opposition over her positions on vaccines and abortion, over industry ties, and over her support for the FDA's authorization of fruit-flavoured vapes. At her September confirmation hearing she argued that flavoured vapes could help some adults quit smoking — the position that made her a live question for the nicotine and tobacco business, and now the reason the question is open again.
The White House is reportedly considering Sen. Roger Marshall of Kansas, a former obstetrician who recently lost his reelection bid, as a replacement. Kyle Diamantas, the FDA's Deputy Commissioner for Food, is serving as acting commissioner in the meantime.
Get this every Thursday. The week in guns, booze and tobacco, in one quick read.
Comments
No comments yet - be the first to post one.
More from Tobacco
All Tobacco
The FDA's New Transparency Roadmap, and What It Means for PMTA
Schumer Presses the FDA on Illicit Chinese Vapes, and Asks for Answers in 30 Days
FDA Folds Tobacco Establishment Registration and Product Listing Into One Form 3741
FDA Names Bret Koplow Permanent Director of the Center for Tobacco Products
The Week In Guns, Booze & Tobacco. In One Quick Read.
The stories that actually mattered, from ATF moves to industry money to what everyone's talking about. Every Thursday. No junk.
Unsubscribing is one click — the link is in every edition.
We store your address to send the newsletter and nothing else.